Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: TORG1426

被引：0
|
作者：
Naoki, K. [1 ]
Ichikawa, Y. [2 ]
Bessho, A. [3 ]
Hosokawa, S. [3 ]
Shimokawa, T. [4 ]
Yomota, M. [5 ]
Hosomi, Y. [5 ]
Otani, S. [1 ]
Nakahara, Y. [1 ]
Iwasawa, S. [6 ]
Tokito, T. [7 ]
Seki, N. [2 ]
Okamoto, H. [8 ]
机构：
[1] Kitasato Univ, Sch Med, Resp Med, Sagamihara, Kanagawa, Japan
[2] Teikyo Univ, Div Med Oncol, Dept Internal Med, Sch Med, Tokyo, Japan
[3] Japanese Red Cross Okayama Hosp, Resp Med, Okayama, Japan
[4] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[6] Chiba Univ, Chiba, Japan
[7] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
[8] Thorac Oncol Res Grp, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; performance status; nab-Paclitaxel;
D O I：
10.1016/j.jtho.2019.08.730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-15
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [31] Phase 2 Trial of Nab-Paclitaxel Plus Carboplatin for Advanced NSCLC in Patients at Risk of Bleeding From VEGF Directed Therapies
    Bertino, E. M.
    Williams, T. M.
    Shilo, K.
    Villalona-Calero, M. A.
    Phillips, G. S.
    Mo, X.
    Otterson, G. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S45 - S45
  • [32] Phase II trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF-directed therapies
    Bertino, E. M.
    Otterson, G. A.
    Villalona-Calero, M. A.
    Nana-Sinkam, S. P.
    Ghany, A. M.
    Donthireddy, K. R.
    Karim, N. F. Abdel
    Cantrell, S.
    Phillips, G. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Phase 2 Trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF directed therapies
    Bertino, Erin M.
    Villalona-Calero, Miguel A.
    Nana-Sinkam, Patrick
    Cantrel, Sarah
    Rahmani, Meliha
    Symmes, Carrie
    Phillips, Gary S.
    Otterson, Gregory A.
    CANCER RESEARCH, 2012, 72
  • [34] Pyrotinib plus nab-paclitaxel in patients with HER2-positive advanced or metastatic breast cancer: A multicenter, single-arm, open-label phase 2 trial.
    Li, Huan
    Li, Zhaohui
    Yan, Min
    Cui, Xiujie
    Ji, Xuening
    Fang, Fenqi
    Zhang, Yuyang
    Wang, Xiaoxin
    Wang, Yan
    Guo, Xiangyu
    Jing, Mingxi
    Gao, Zhichao
    Cao, Hui
    Dong, Fangyuan
    Wu, Jie
    Jiang, Cui
    Duan, Yangyang
    Li, Xiaorui
    Jiang, Yujun
    Sun, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for advanced metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase II study
    Du, J.
    Tong, F.
    Sha, H.
    Sun, Y.
    Zhu, Y.
    Qi, L.
    Li, X.
    Li, W.
    Yang, Y.
    Li, Z.
    Xu, C.
    Ni, J.
    Zhang, X.
    Zhu, C.
    Wang, X.
    Qian, X.
    Liu, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1535 - S1535
  • [36] Blood Based Mirna Analysis From A Phase 2 Trial Of Nab-paclitaxel Plus Carboplatin For Advanced NSCLC In Patients Ineligible For Bevacizumab
    Otterson, G. A.
    Nana-Sinkam, P.
    Crawford, M.
    Bertino, E.
    Villalona-Calero, M. A.
    Rahmani, M.
    Symmes, C.
    Phillips, G. S.
    Wu, X.
    Yu, L.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S285 - S285
  • [37] Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II study
    Zhou, Haiyu
    Lin, Lili
    Qin, Tao
    Ren, Wei
    Tan, Yujie
    Yang, Qiong
    Xu, Huixin
    Xie, Xinxin
    Chen, Yongjian
    Liu, Shengbo
    Li, Xing
    Li, Zhihua
    Hu, Hai
    Yu, Yunfang
    Yao, Herui
    JOURNAL OF THORACIC DISEASE, 2021, 13 (11) : 6468 - 6475
  • [38] Nab-paclitaxel and cisplatin-based concurrent chemoradiotherapy for locally advanced cervical cancer: A prospective, single-arm phase II clinical trial
    Li, Mingyi
    Qin, Qinghua
    Zhang, Yiqian
    Wu, Qiuyan
    Li, Zhouyu
    Yang, Xinglong
    Cai, Zhantuo
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S72 - S72
  • [39] A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder
    Grivas, Petros D.
    Hussain, Maha
    Hafez, Khaled
    Daignault-Newton, Stephanie
    Wood, David
    Lee, Cheryl T.
    Weizer, Alon
    Montie, James E.
    Hollenbeck, Brent
    Montgomery, Jeffrey S.
    Alva, Ajjai
    Smith, David C.
    UROLOGY, 2013, 82 (01) : 111 - 117
  • [40] Phase II trial of neoadjuvant carboplatin and nab-paclitaxel in patients with locally advanced triple negative breast cancer
    Yuan, Y.
    Frankel, P.
    Li, M.
    Kruper, L.
    Jones, V.
    Treece, T.
    Waisman, J.
    Yim, J.
    Tumyan, L.
    Schmolze, D.
    Hurria, A.
    Yeon, C.
    Mortimer, J.
    Somlo, G.
    CANCER RESEARCH, 2019, 79 (04)
12345